https://wikimd.org/index.php?action=history&feed=atom&title=Minamestane 2026-04-25T19:07:41Z Revision history for this page on the wiki MediaWiki 1.44.2 https://wikimd.org/index.php?title=Minamestane&diff=5809525&oldid=prev 2024-05-22T17:54:17Z

<p>CSV import</p> <p><b>New page</b></p><div>[[File:Minamestane.svg|thumb|Minamestane.svg]] &#039;&#039;&#039;Minamestane&#039;&#039;&#039; is a [[steroidal aromatase inhibitor]] that has been studied for its potential use in the treatment of [[breast cancer]]. It belongs to a class of drugs known as [[aromatase inhibitors]], which work by blocking the enzyme [[aromatase]], thereby reducing the production of [[estrogen]] in the body. This reduction in estrogen levels can help slow the growth of certain types of breast cancer that rely on estrogen to grow.<br /> <br /> ==Mechanism of Action==<br /> Minamestane inhibits the enzyme [[aromatase]], which is responsible for the conversion of [[androgens]] to [[estrogens]]. By inhibiting this enzyme, minamestane reduces the overall levels of estrogen in the body. This is particularly beneficial in the treatment of [[hormone receptor-positive breast cancer]], where the growth of cancer cells is driven by estrogen.<br /> <br /> ==Clinical Use==<br /> Minamestane has been investigated in clinical trials for its efficacy in treating [[postmenopausal women]] with [[hormone receptor-positive breast cancer]]. It is considered a potential alternative to other aromatase inhibitors such as [[anastrozole]], [[letrozole]], and [[exemestane]].<br /> <br /> ==Side Effects==<br /> As with other aromatase inhibitors, minamestane may cause side effects, including:<br /> * [[Hot flashes]]<br /> * [[Joint pain]]<br /> * [[Osteoporosis]]<br /> * [[Fatigue]]<br /> * [[Nausea]]<br /> <br /> ==Comparison with Other Aromatase Inhibitors==<br /> Minamestane is similar to other aromatase inhibitors like [[anastrozole]], [[letrozole]], and [[exemestane]] in its mechanism of action. However, its specific efficacy and side effect profile may differ, making it a subject of ongoing research.<br /> <br /> ==Research and Development==<br /> Minamestane is still under investigation, and more studies are needed to fully understand its potential benefits and risks. It is not yet widely available for clinical use and remains a topic of interest in the field of [[oncology]].<br /> <br /> ==See Also==<br /> * [[Aromatase inhibitor]]<br /> * [[Breast cancer]]<br /> * [[Hormone therapy (oncology)]]<br /> * [[Postmenopausal]]<br /> <br /> ==References==<br /> {{Reflist}}<br /> <br /> ==External Links==<br /> {{No external links}}<br /> <br /> [[Category:Breast cancer]]<br /> [[Category:Aromatase inhibitors]]<br /> [[Category:Hormonal antineoplastic drugs]]<br /> [[Category:Experimental cancer drugs]]<br /> [[Category:Steroidal aromatase inhibitors]]<br /> <br /> {{medicine-stub}}</div>

Prab